ID   VUB13_FXS
AC   CVCL_9849
SY   VUBe013-A
DR   hPSCreg; VUBe013-A
DR   ISCR; 240
DR   SKIP; SKIP001835
DR   Wikidata; Q54993398
RX   PubMed=20224973;
RX   PubMed=27690107;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; 3775; FMR1; Repeat_expansion; CGG[2000]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=20224973; DOI=10.1007/s11626-010-9284-4;
RA   Mateizel I., Spits C., De Rycke M., Liebaers I., Sermon K.;
RT   "Derivation, culture, and characterization of VUB hESC lines.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:300-308(2010).
//
RX   PubMed=27690107; DOI=10.3390/genes7100077;
RA   Mor-Shaked H., Eiges R.;
RT   "Modeling fragile X syndrome using human pluripotent stem cells.";
RL   Genes (Basel) 7:77.1-77.19(2016).
//